241
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Combined measurements of fractional exhaled nitric oxide and nasal nitric oxide levels for assessing upper airway diseases in asthmatic patients

, MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, , MD, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, PhD, , MD, PhD & , MD, PhD show all
Pages 300-309 | Received 27 Jan 2017, Accepted 14 May 2017, Published online: 21 Jun 2017

References

  • Dixon AE, Kaminsky DA, Holbrook JT, Wise RA, Shade DM, Irvin CG. Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest 2006;130(2):429–435.
  • Marseglia GL, Merli P, Caimmi D, Licari A, Labó E, Marseglia A, et al. Nasal disease and asthma. Int J Immunopathol Pharmacol 2011;24(4 Suppl):7–12.
  • Licari A, Castagnoli R, Denicolò CF, Rossini L, Marseglia A, Marseglia GL. The nose and the lung: united airway disease? Front Pediatr 2017;5:44.
  • Ohta K, Bousquet PJ, Aizawa H, Akiyama K, Adachi M, Ichinose M, et al. Prevalence and impact of rhinitis in asthma. SACRA, a cross-sectional nation-wide study in Japan. Allergy 2011;66(10):1287–1295.
  • Tajiri T, Niimi A, Matsumoto H, Ito I, Oguma T, Otsuka K, et al. Prevalence and clinical relevance of allergic rhinitis in patients with classic asthma and cough variant asthma. Respiration 2014;87(3):211–218.
  • Bousquet J, Gaugris S, Kocevar VS, Zhang Q, Yin DD, Polos PG, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy. Clin Exp Allergy 2005;35(6):723–727.
  • Talay F, Kurt B, Gurel K, Yilmaz F. Paranasal computed tomography results in asthma patients: association between sinus sites and allergen types. Allergy Asthma Proc 2008;29(5):475–479.
  • Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47(1):25–29.
  • Bousquet J, Chanez P, Lacoste JY, Enander I, Venge P, Peterson C, et al. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 1991;88(4):649–660.
  • Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26(3):523–548.
  • American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171(8):912–930.
  • Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184(5):602–615.
  • Tsoukias NM, George SC. Impact of volume-dependent alveolar diffusing capacity on exhaled nitric oxide concentration. Ann Biomed Eng 2001;29(9):731–739.
  • Condorelli P, Shin HW, Aledia AS, Silkoff PE, George SC. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J Appl Physiol (1985) 2007;102(1):417–425.
  • Lundberg JO. Nitric oxide and the paranasal sinuses. Anat Rec (Hoboken) 2008;291(11):1479–1484.
  • Lee KJ, Cho SH, Lee SH, Tae K, Yoon HJ, Kim SH, et al. Nasal and exhaled nitric oxide in allergic rhinitis. Clin Exp Otorhinolaryngol 2012;5(4):228–233.
  • Takeno S, Noda N, Hirakawa K. Measurements of nasal fractional exhaled nitric oxide with a hand-held device in patients with allergic rhinitis: relation to cedar pollen dispersion and laser surgery. Allergol Int 2012;61(1):93–100.
  • Horváth I, Loukides S, Wodehouse T, Csiszér E, Cole PJ, Kharitonov SA, et al. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 2003;58(1):68–72.
  • Lindberg S, Cervin A, Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol 1997;117(1):113–117.
  • Jeong JH, Yoo HS, Lee SH, Kim KR, Yoon HJ, Kim SH. Nasal and exhaled nitric oxide in chronic rhinosinusitis with polyps. Am J Rhinol Allergy 2014;28(1):e11–e16.
  • Nakano H, Ide H, Imada M, Osanai S, Takahashi T, Kikuchi K, et al. Reduced nasal nitric oxide in diffuse panbronchiolitis. Am J Respir Crit Care Med 2000;162(6):2218–2220.
  • Hellings PW, Fokkens WJ. Allergic rhinitis and its impact on otorhinolaryngology. Allergy 2006;61(6):656–664.
  • Ohta K, Ichinose M, Nagase H, Yamaguchi M, Sugiura H, Tohda Y, et al. Japanese guideline for adult asthma 2014. Allergol Int 2014;63(3):293–333.
  • Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31(1):143–178.
  • Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M, et al. Clinical practice guideline (update): adult sinusitis executive summary. Otolaryngol Head Neck Surg 2015;152(4):598–609.
  • Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8–160.
  • Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 2006;118(5 Suppl):S17–S61.
  • Laszlo G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax 2006;61(9):744–746.
  • Yamada T, Yamamoto H, Kubo S, Sakashita M, Tokunaga T, Susuki D, et al. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis. Allergy Asthma Proc 2012;33(2):e9–e16.
  • Shiga H, Yamamoto J, Kitamura M, Nakagawa H, Matsubasa T, Seo A, et al. Combinations of two odorants of smell identification test for screening of olfactory impairment. Auris Nasus Larynx 2014;41(6):523–527.
  • Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1997;117(3 Pt 2):S35–S40.
  • Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14(4):902–907.
  • Matsunaga K, Hirano T, Akamatsu K, Koarai A, Sugiura H, Minakata Y, et al. Exhaled nitric oxide cutoff values for asthma diagnosis according to rhinitis and smoking status in Japanese subjects. Allergol Int 2011;60(3):331–337.
  • Asano T, Takemura M, Fukumitsu K, Takeda N, Ichikawa H, Hijikata H, et al. Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status. Allergol Int 2017;66(2):344–350.
  • Kobayashi Y, Asako M, Ooka H, Kanda A, Tomoda K, Yasuba H. Residual exhaled nitric oxide elevation in asthmatics is associated with eosinophilic chronic rhinosinusitis. J Asthma 2015;52(10):1060–1064.
  • Kariya S, Okano M, Higaki T, Noyama Y, Haruna T, Ishihara H, et al. Chronic rhinosinusitis patients have decreased lung function. Int Forum Allergy Rhinol 2014;4(10):828–833.
  • Lin DC, Chandra RK, Tan BK, Zirkle W, Conley DB, Grammer LC, et al. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy 2011;25(4):205–208.
  • Yuksel H, Kirmaz C, Yilmaz O, Pinar E, Vatansever S, Degirmenci PB, et al. Nasal mucosal expression of nitric oxide synthases in patients with allergic rhinitis and its relation to asthma. Ann Allergy Asthma Immunol 2008;100(1):12–16.
  • Struben VM, Wieringa MH, Feenstra L, de Jongste JC. Nasal nitric oxide and nasal allergy. Allergy 2006;61(6):665–670.
  • Gupta N, Goel N, Kumar R. Correlation of exhaled nitric oxide, nasal nitric oxide and atopic status: a cross-sectional study in bronchial asthma and allergic rhinitis. Lung India 2014;31(4):342–347.
  • Olin AC, Hellgren J, Karlsson G, Ljungkvist G, Nolkrantz K, Torén K. Nasal nitric oxide and its relationship to nasal symptoms, smoking and nasal nitrate. Rhinology 1998;36(3):117–121.
  • Gaga M, Lambrou P, Papageorgiou N, Koulouris NG, Kosmas E, Fragakis S, et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000;30(5):663–669.
  • Bousquet J, Van Cauwenberge P, Khaltaev N, Group AW, Organization WH. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):S147–S334.
  • Passalacqua G, Ciprandi G, Canonica GW. The nose-lung interaction in allergic rhinitis and asthma: united airways disease. Curr Opin Allergy Clin Immunol 2001;1(1):7–13.
  • Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43(2):109–142.
  • Arnal JF, Flores P, Rami J, Murris-Espin M, Bremont F, Pasto I, et al. Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J 1999;13(2):307–312.
  • Jain B, Rubinstein I, Robbins RA, Leise KL, Sisson JH. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 1993;191(1):83–88.
  • Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996;75(4):319–322.
  • Deja M, Busch T, Bachmann S, Riskowski K, Campean V, Wiedmann B, et al. Reduced nitric oxide in sinus epithelium of patients with radiologic maxillary sinusitis and sepsis. Am J Respir Crit Care Med 2003;168(3):281–286.
  • Krantz C, Janson C, Borres MP, Nordvall L, Alving K, Malinovschi A. Nasal nitric oxide is associated with exhaled NO, bronchial responsiveness and poor asthma control. J Breath Res 2014;8(2):026002.
  • Heffler E, Pizzimenti S, Badiu I, Guida G, Ricciardolo FL, Bucca C, et al. Nasal nitric oxide is a marker of poor asthma control. J Breath Res 2013;7(2):026009.
  • Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Clin Exp Allergy 2001;31(4):616–624.
  • Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2000;85(2):111–114.
  • Lundberg JO, Weitzberg E, Rinder J, Rudehill A, Jansson O, Wiklund NP, et al. Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa. Eur Respir J 1996;9(7):1344–1347.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.